Furthermore, our metabolomics studies utilizing human pancreatic tumor specimens also indicate alterations in nucleotide intermediates and differential overall metabolite profiles, in a MUC16 expression-dependent manner. This evidence concerns the gene MUC16 and pancreatic neoplasm.